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The Epstein-Barr virus (EBV) is the causative agent or cofactor in the aetiology of several 
human malignancies such as Burkitt’s lymphoma, Hodgkin’s disease, nasopharyngeal 
carcinoma (NPC) and lymphoproliferative disorder in immunocompromised patients. 
EBV is a lymphotropic !-herpes virus infecting more than 90 percent of the population 
worldwide. Following acute infection the virus establishes a life-long latency in resting 
memory B cells. The virus is remarkable for the efficiency with which it causes 
proliferation and immortalization of the infected B cells through expression of several 
latent gene products. All of the viral EBNA proteins have been proposed to play a role in 
the control of gene expression in the EBV infected lymphoblastoid cell.  
   The present thesis is mainly focused on further elucidating the molecular mechanisms of 
the EBNA1 and EBNA5 proteins using proteomic technologies as approach. In paper I we 
used an improved tandem affinity purification procedure for identification and 
characterization of factors in the EBNA5 interaction proteome. The majority of the 37 
validated interactors could be assigned to one of three groups according to function: 
protein folding and degradation, pre-mRNA processing, or ribosomal proteins, 
implicating functional relationships with EBNA5 in these processes. We also showed that 
EBNA5 is part of high molecular protein complexes, supporting the notion that functional 
units in the cell are not single proteins but well-structured complexes composed of 
multiple proteins i.e. modules. 
   The previously reported repressor activity of EBNA5 was further investigated in paper 
II. The study identified the novel interactor BAG2 as a major target for the function of 
EBNA5 via the chaperone-mediated folding and proteasome-degradation pathways. 
Taken together, the results are consistent with the hypothesis that EBNA5 tune the 
balance between protein rescue and destruction in a way that disfavour the path of 
degradation.   
   The constituents of the large macromolecular complex that initiates transcription from 
the viral C promoter were investigated in paper III. Using a DNA affinity procedure we 
showed that the transcription factors E2F1, ARID3A/Bright and Oct-2 binds the Cp as 
well as EBNA1 and oriPI, possibly facilitating long-distance promoter-enhancer 
interactions.  
   While the study of genes and proteins continues to be important, looking at isolated 
components is not enough to understand most biological processes. Modularity has been 
proposed as a general principle for the molecular architecture of living systems. These 
assemblies interact with other large protein complexes, thus the proteins are part of a 
protein-protein interaction network inside the cell. A common feature of these interaction 
networks is that it contains junctions of proteins that are highly interconnected, also called 
hubs. Hubs have a tendency of being essential and involved in cancer development. Two 
central pathways in cancer biology are the Rb- and p53-pathways, which are targets for 
both EBNA1 and EBNA5 action. This is consistent with the hypothesis that several viral 
proteins target the same hubs in the host, which ensures the takeover of the cellular 
machineries essential for the viral infection and persistence processes, and contribute to 
the robustness of the viral infectious system.  
